These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 31851879

  • 1. Effects of cotrimoxazole prophylaxis on Talaromyces marneffei infection in HIV/AIDS patients receiving antiretroviral therapy: a retrospective cohort study.
    Jiang J, Qin F, Meng S, Nehl EJ, Huang J, Liu Y, Zou J, Dong W, Huang J, Chen H, Zang N, Liang B, Ning C, Liao Y, Luo C, Liu H, Liu X, Wang J, Zhou O, Le T, Ye L, Wu F, Liang H.
    Emerg Microbes Infect; 2019; 8(1):367-376. PubMed ID: 31851879
    [Abstract] [Full Text] [Related]

  • 2. Effect and Mechanism of Cotrimoxazole Against Talaromyces marneffei in vitro.
    Chen J, Chen R, Wei W, Qin F, Chen X, He J, Zhang H, Wang G, Shi M, Qin T, Liao Y, Wu Y, Lu B, Tao X, Ye L, Liang H, Jiang J.
    Mycopathologia; 2022 Dec; 187(5-6):579-593. PubMed ID: 36318375
    [Abstract] [Full Text] [Related]

  • 3. Effects of Talaromyces marneffei infection on mortality of HIV/AIDS patients in southern China: a retrospective cohort study.
    Jiang J, Meng S, Huang S, Ruan Y, Lu X, Li JZ, Wu N, Huang J, Xie Z, Liang B, Deng J, Zhou B, Chen X, Ning C, Liao Y, Wei W, Lai J, Ye L, Wu F, Liang H.
    Clin Microbiol Infect; 2019 Feb; 25(2):233-241. PubMed ID: 29698815
    [Abstract] [Full Text] [Related]

  • 4. Burden of Talaromyces marneffei infection in people living with HIV/AIDS in Asia during ART era: a systematic review and meta-analysis.
    Qin Y, Huang X, Chen H, Liu X, Li Y, Hou J, Li A, Yan X, Chen Y.
    BMC Infect Dis; 2020 Jul 29; 20(1):551. PubMed ID: 32727383
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Characteristics and risk factors for readmission in HIV-infected patients with Talaromyces marneffei infection.
    Shi M, Qin Y, Chen S, Wei W, Meng S, Chen X, Li J, Li Y, Chen R, Su J, Yuan Z, Wang G, Qin Y, Ye L, Liang H, Xie Z, Jiang J.
    PLoS Negl Trop Dis; 2023 Oct 29; 17(10):e0011622. PubMed ID: 37816066
    [Abstract] [Full Text] [Related]

  • 8. [Effect of co-trimoxazole prophylaxis used for AIDS patients under anti-retroviral therapy].
    Yang W, Liang Y, Li J, Ma Y, Li N, Sun D, Wang Z.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2014 Jun 29; 35(6):689-94. PubMed ID: 25174473
    [Abstract] [Full Text] [Related]

  • 9. Clinical characteristics and risk factors for poor prognosis among HIV patients with Talaromyces marneffei bloodstream infection.
    Sun J, Sun W, Tang Y, Zhang R, Liu L, Shen Y, Wang J, Chen J, Qi T, Wang Z, Song W, Lin Y, Xu S, Lu H.
    BMC Infect Dis; 2021 Jun 01; 21(1):514. PubMed ID: 34074256
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effect of AIDS-defining events at initiation of antiretroviral therapy on long-term mortality of HIV/AIDS patients in Southwestern China: a retrospective cohort study.
    Huang Y, Zhou O, Zheng Z, Xu Y, Shao Y, Qin C, Qin F, Lai J, Liu H, Chen R, Ye L, Liang H, Qin X, Jiang J.
    AIDS Res Ther; 2020 Jul 17; 17(1):44. PubMed ID: 32680536
    [Abstract] [Full Text] [Related]

  • 12. Cotrimoxazole prophylaxis decreases tuberculosis risk among Asian patients with HIV.
    Ku SW, Jiamsakul A, Joshi K, Pasayan MKU, Widhani A, Chaiwarith R, Kiertiburanakul S, Avihingsanon A, Ly PS, Kumarasamy N, Do CD, Merati TP, Nguyen KV, Kamarulzaman A, Zhang F, Lee MP, Choi JY, Tanuma J, Khusuwan S, Sim BLH, Ng OT, Ratanasuwan W, Ross J, Wong WW, TREAT Asia HIV Observational Database (TAHOD) of IeDEA Asia-Pacific.
    J Int AIDS Soc; 2019 Mar 17; 22(3):e25264. PubMed ID: 30924281
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effect of combination antiretroviral therapy on the clinical manifestations, radiological characteristics, and disease severity of HIV-associated Talaromyces marneffei infection.
    Shi X, Yan Q, Zhan Y, Shi C, Song F, Wang L, Qi T, Lu H, Shan F, Shi Y.
    Int J STD AIDS; 2020 Jul 17; 31(8):747-752. PubMed ID: 32631212
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Incidence of malaria by cotrimoxazole use in HIV-infected Ugandan adults on antiretroviral therapy: a randomised, placebo-controlled study.
    Kasirye RP, Baisley K, Munderi P, Levin J, Anywaine Z, Nunn A, Kamali A, Grosskurth H.
    AIDS; 2016 Feb 20; 30(4):635-44. PubMed ID: 26558729
    [Abstract] [Full Text] [Related]

  • 20. Clinical Characteristics of HIV-Associated Talaromyces marneffei Infection of Intestine in Southern China.
    Xie Z, Lai J, Peng R, Mou M, Liang H, Ning C.
    Int J Infect Dis; 2022 Jul 20; 120():48-50. PubMed ID: 35398298
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.